The maturity date of the Amended Credit Facility is September 3, 2023. The Amended Credit Facility increased the aggregate principal amount of the credit facilities to $270 million. The $270 million Amended Credit Facility consists of a $200 million term loan (“Term Loan Facility”) and a $70 million revolving credit facility (“Revolving Credit Facility”), together with an option to increase the facility by up to an additional $75 million Revolving Credit Facility.
As of September 30, 2022, we had an outstanding principal balance of $27 million under the Term Loan Facility, a $0.6 million letter of credit and no borrowings under the Revolving Credit Facility; $69.4 million remained available for borrowing. The entire outstanding principal balance is due in the next twelve months.
We are required to make quarterly principal payments under the Term Loan Facility on each Term Loan Installment Date, commencing on December 31, 2020, in an amount equal to (x) the percentage set forth opposite the applicable period during which such Term Loan Installment Date occurs (i.e., 1.25% for the period from December 31, 2020 to September 30, 2021, and 2.50% for the period from December 31, 2021 and thereafter) multiplied by (y) $200 million.
Commencing with the delivery of the compliance certificate for fiscal year 2022, we may be required to prepay borrowings under the Amended Credit Facility using excess cash flows for each fiscal year, depending on the Company’s leverage ratio.
Borrowings are secured by liens on substantially all of our real and personal property.
In addition to other customary covenants for a facility of this nature, as of September 30, 2022, we are required to maintain a Total Leverage Ratio (as defined in the Amended Credit Facility) of no more than 4.0:1 and Fixed Charge Coverage Ratio (as defined in the Amended Credit Facility) of at least 1.15:1. As of September 30, 2022, our Total Leverage Ratio and Fixed Charge Coverage Ratio were 0.2:1 and 3.8:1, respectively.
As of September 30, 2022, the interest rate under the Amended Credit Facility is LIBOR plus a margin ranging from 1.00% to 2.00%, or a base rate (as defined in the Amended Credit Facility) plus a margin ranging from 0.00% to 1.00%, or the Prime Rate. The applicable margins vary depending on the Company’s leverage ratio. Commitment fees are equal to the daily average unused revolving commitment multiplied by the commitment fee percentage, ranging from 0.175% to 0.325%, based on our leverage ratio. As of September 30, 2022, the interest rate on the Term Loan Facility was 4.12%, or LIBOR plus a 1.00% margin.
On the terms and subject to some conditions, we may, at any time before the maturity date, request an increase of the Revolving Credit Facility, provided that each such increase is equal to $15 million or an integral multiple of $1 million in excess and, after giving effect to the requested increase, the aggregate amount of the increases in the total revolving loan commitment shall not exceed $75 million.
We may prepay borrowings under the Amended Credit Facility revolving loan without penalty (subject to certain conditions and certain charges applicable to the prepayment of LIBOR borrowings prior to the end of the applicable interest period). Once reduced or cancelled, the Revolving Credit Facility may not be increased or reinstated without the prior written consent of all lenders. During the first nine months of 2022, we made $48 million in optional prepayments on the Term Loan Facility in addition to a $15 million in mandatory payments.
As of September 30, 2022, $26.2 million, representing $27.0 million outstanding loan amount under the Amended Credit Facility, net of $0.8 million unamortized debt issuance costs, is presented in the Current liabilities section of the Company’s consolidated balance sheet as “Current maturities of long-term debt”.
We believe that our anticipated operating cash flow and the $69.4 million available under our Amended Credit Facility as of September 30, 2022 will be sufficient to sustain operations for the twelve months from filing of Form 10-Q for the quarter ended September 30, 2022 and fulfill our capital expenditure plans. However, spikes in COVID-19 cases or new variants thereof, other contagious diseases or viruses, or financial, economic, competitive, regulatory, and other factors, many of which are beyond our control, could negatively impact our operations. If we are unable to generate sufficient cash flow in the upcoming months or if our cash needs exceed our borrowing capacity under the Amended Credit Facility, we could be required to adopt one or more alternatives, such as reducing, delaying or eliminating planned capital expenditures, selling assets, restructuring debt or issuing additional equity.